Crystal structures of mefloquine-oxazolidine derivatives, 4-[3-(halophenyl)hexahydro[1,3]oxazolo[3,4-a]pyridin-1-yl]- 2,8-bis(trifluoromethyl)quinolines.

Authors: Gonçalves,R.S.B.; De Souza, M.V.N.; Wardell, J.L.; Wardell, S.M.S.V.


Abstract

Crystal structures are reported for five racemic 4-{3-(halophenyl)hexahydro[1,3]oxazolo[3,4-a]pyridin-1- yl}-2,8-bis(trifluoromethyl)quinolines, 2, namely (2: X = 2-F, 3-Br, 4-Cl, 4-Br and 4-F), prepared from mefloquine and XC6H5CHO. In each case, the compound crystallizes in the triclinic space group, P1̄, with Z = 2. All molecules have ‘‘F’’ shapes with the X-phenyl and quinoline rings lying on one side of the best plane through the fused oxazolidine- piperidine rings. Differences in the conformations of the molecules are indicated by the differences in the interplanar angles. In each case, the supramolecular arrangements are made up from combinations of π … π and some of C-H…X and C-X… π (X = halo) interactions. Two similar structural sub-sets found in the crystal structures of the five derivatives are centrosymmetric π … π-linked dimers and centrosymmetric cage-like dimers. The cage-like dimers, formed by the intermeshing of the rings of the monomers, are generated from different weak intermolecular interactions, which include C-H…X and C-X… π (X = halo) interactions. Comparisons are made between the activities of the mefloquine- oxazolidine derivatives in in-vitro tests against the multidrug-resistant tuberculosis strain and conformations, as measured by interplanar angles.
Keywords: X-ray crystallography; Quinoline derivatives; Mefloquine derivatives; π … π interactions: C-H…X (X = halo) interactions; C-X … π (X = halo) interactions Document Type: Research Article DOI: http://dx.doi.org/10.1524/zkri.2013.1691 Publication date: 1 de dezembro de 2013

Compartilhar publicação

Facebook
Twitter
Email
LinkedIn
WhatsApp

Deixe seu comentário

Compartilhar

Sobre a SSCDT

Nosso grupo de pesquisa está situado em Farmanguinhos e atualmente é o maior laboratório farmacêutico oficial vinculado ao Ministério da Saúde. Farmanguinhos produz mais de um bilhão de medicamentos por ano para os programas estratégicos do Governo Federal, além de atender demandas emergenciais no Brasil e no exterior.

posts Recentes